| Name: | Bosentan Sulfoxide |
| Catalogue No. | VE007406 |
| CAS No. | N/A |
| Molecular Formula | C27H29N5O5S |
| Molecular Weight | 535.61 g/mol |
| Status | In-Stock |
| IUPAC Name | 4-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)benzenesulfinamide |
| Description | Bosentan Sulfoxide or 4-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)benzenesulfinamide is associate impurity of Bosentan. Bosentan is a dual endothelin receptor antagonist. Bosentan is employed to treat pulmonary hypertension by blocking the action of endothelin molecules . |
| References | “Sci-Hub | Bosentan Therapy for Portopulmonary Hypertension | 10.1183/09031936.05.00080804.” Hkvisa.net, 2022, sci-hub.hkvisa.net/10.1183/09031936.05.00080804. |
